How long can COVID-related lung damage be prevented or treated

Published Date: 02 Mar 2023

A group of medical researchers from Stanford University, together with colleagues from the Taiwan Biomedical Research Institute, have discovered a way to prevent or treat chronic lung disease. ...

Read Full News

Latest News

Spousal Dementia Tied to Higher Dementia Risk

Spouses of individuals with dementia have a significantly higher risk of developing dementia, new research shows.

Romanian Healthcare Workers Strike Over Wage Bill Needed to Secure EU Funds

Thousands of Romanian doctors, nurses and other health workers went on an indefinite strike ⁠for the first time in a decade on Tuesday, protesting job freezes and a public...

Infections Tied to Increased Risk for Brain Disorders

Hospitalization due to an acute infection, especially infectious encephalitides, is linked to increased risk for psychiatric and neurologic disorders, a new study shows.

The Restorative Power of ‘Sacred Moments’ in Medicine

Deep human connection can be a potent antidote to burnout. Here’s how to cultivate meaning in an increasingly rushed healthcare system.

US FDA Approves Outlook Therapeutics' Eye Disease Drug

Outlook Therapeutics said on Friday the U.S. Food and Drug Administration has approved its drug for ⁠a type of eye disease that can cause vision loss.

Nasal IgA Protects Against H1N1, SARS-CoV-2 Infections

High baseline nasal IgA, not serum IgG, was linked to lower risk for influenza A H1N1 infection in a real-world study.

Todays Updates

Trial Challenges Indefinite Maintenance for Multiple Myeloma

A randomized trial questions whether patients with standard-risk multiple myeloma need indefinite lenalidomide maintenance.

Blinatumomab May Improve Survival in High-Risk Adult B-ALL

A phase 2 trial evaluates the benefit of adding blinatumomab to consolidation therapy in adults with high-risk Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.

Todays Updates

Trial Challenges Indefinite Maintenance for Multiple Myeloma

A randomized trial questions whether patients with standard-risk multiple myeloma need indefinite lenalidomide maintenance.

Blinatumomab May Improve Survival in High-Risk Adult B-ALL

A phase 2 trial evaluates the benefit of adding blinatumomab to consolidation therapy in adults with high-risk Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.

Latest News

Spouses of individuals with dementia have a significantly higher risk of developing dementia, new research shows.

Thousands of Romanian doctors, nurses and other health workers went on an indefinite strike ⁠for the first time in a decade on Tuesday, protesting job freezes and a public...

Hospitalization due to an acute infection, especially infectious encephalitides, is linked to increased risk for psychiatric and neurologic disorders, a new study shows.

Deep human connection can be a potent antidote to burnout. Here’s how to cultivate meaning in an increasingly rushed healthcare system.

Outlook Therapeutics said on Friday the U.S. Food and Drug Administration has approved its drug for ⁠a type of eye disease that can cause vision loss.

High baseline nasal IgA, not serum IgG, was linked to lower risk for influenza A H1N1 infection in a real-world study.

News All Time

Cefazolin Noninferior to Penicillins for MSSA Bacteremia

Cefazolin is noninferior to antistaphylococcal penicillins for methicillin-susceptible Staphylococcus aureus bacteremia and is associated with a lower risk for acute kidney injury.

Tentacular Cyclosporiasis Outbreak Stymies Epidemiology Efforts

Confirmed case count across 34 states is five times the number reported last summer, the CDC says.

Transport Of Dead Bodies Within Congo Risks Further Ebola Spread, UN Agency Warns

The transport of Ebola victims' bodies between different areas of the Democratic Republic of Congo, often for funerals in their home communities, risks further ⁠spreading...

Noninvasive Ventilation May Lower Tracheostomy Need in BPD

In preemies with bronchopulmonary dysplasia on home respiratory support, noninvasive positive airway pressure is linked to shorter hospital stays and less healthcare use than tracheostomy ventilation.

Ensitrelvir Reduces COVID Risk Among Contacts Post-Exposure

Household contacts who initiate ensitrelvir vs placebo within 72 hours of symptom onset in the index patient have lower risk of developing COVID, with no apparent safety concerns.

How to Teach Professionalism? Ditch the Deficiency Focus

Teaching professionalism in medical school is required, but how best to do it? Move beyond a deficiency focus, experts say. Emphasize positive examples of professionalism.

Anemia Leads List of Factors That Affect BLVR Failure

Recognizing the impact of comorbidities may guide patient selection and improve outcomes.

Paid Parental Leave for Med School Faculty Often Lacking

Many medical schools don’t offer nationally recommended levels of paid parental leave.

Congo's Ebola Outbreak Spreads to Two More Provinces

The Ebola outbreak in the Democratic Republic of Congo has spread to two more northeastern provinces, Haut-Uele ⁠and Tshopo, the country's public health institute said in...

‘Super Movers’ May Have Slower Cognitive Decline

Fast-walking ‘super movers’ aged 80 years or older have about half the risk for cognitive impairment but no less Alzheimer’s disease pathology.

Sanofi to Stop Disparaging Rival Flu Vaccine to Stave Off EU Antitrust Fine

French pharmaceutical company Sanofi has offered to state publicly that ⁠a rival flu vaccine is as effective as its own, EU antitrust regulators said on Wednesday of the...

India's Dr Reddy's Says Semaglutide Shipping Disruption to Last Until At Least Late October

India's Dr Reddy's Laboratories said on Thursday that supplies of its generic semaglutide would remain unavailable in India and face disruptions in Canada until at least...
HTTP error: 503HTTP error: 503

Initial Prescription Duration May Shape Benzodiazepine Use

Longer durations of initial prescriptions are associated with prolonged use of benzodiazepines compared with durations of 7 days or less, a large cohort study shows.

Alcohol’s Health Myth Is Over. How to Tell Patients

The science on alcohol has changed dramatically. Here’s how experts say physicians can explain why older advice no longer holds up — and counsel patients without judgment.

Recommended News For You

For relapsed or resistant DLBCL, odronextamab produced positive results.

Alkem introduces cetuximab under the trade name Cetuxa in India.

In cases of locally advanced, potentially curable pancreatic cancer, a combination of drugs enhances the results of radiation therapy.

The pathology of incurable cancers can be predicted thanks to research.

AI is equally capable of reading breast cancer scans as human radiologists.

Radioligand Therapy Set to Transform Oncology Care

The self-sacrificing nature of breast cancer cells has been identified as a possible reason for relapse.

Recommended Articles For You

Clinical Methods in Hematology and Quality Improvement 

Gene-Regulated Hematopoietic Restoration Technologies 

Metabolic Competition Within the Tumor Ecosystem: Mechanisms, Clinical Relevance, and Therapeutic Advances 

Advanced Approaches in Oncology and Patient Outcomes 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

2.

Quads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma

3.

VP Nominee Medical Records Breached; Queen Elizabeth's Cancer; Galaxy Gas Whippets

4.

New study reveals racial disparities in breast cancer diagnosis and outcomes in Canada

5.

Reduced Suicide Rates in Cancer Patients; Enhanced Circadian Rhythm; HIV Vaccine for Cancer Patients?

1.

Unlocking the Power of Cryoprecipitate: A Comprehensive Guide

2.

Comprehensive Standards in Oncology for Modern Medicine

3.

Everything You Need to Know About Leiomyomas: A Comprehensive Guide 

4.

Artificial Intelligence for Early Cancer Detection Leveraging Multi-Omics: A Comprehensive Review

5.

Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

4.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

5.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot